- Strong cash position of over $40 million to fund aggressive expansion timeline
- One of first companies to obtain cannabis production license from Health Canada
- Infrastructure in place to take advantage of projected $9 billion Canadian cannabis market
- Sees ample opportunities in Western Europe with first marketing push in Germany
Abcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF), a manufacturer and distributor of medical cannabis in Canada, is creating a consistent, organically grown, pesticide-free standardized product that is keeping costs down and investors excited. Abcann’s approach to growing cannabis centers on replicating the natural environment of any geographical location for a product that is both superior in quality and repeatable from batch to batch – a key ingredient in the company’s 94.7 percent customer retention rate.
As one of Canada’s first licensed cannabis producers, Abcann is significantly ahead of the curve when it comes to production capacities. The company’s Vanluven Facility, producing 1,000 kg annually, is licensed and fully operational, with an additional bloom chamber being added. Construction on the Kimmett facility, an industry-leading, purpose-built, world class style facility, is under contract with another 65 acres under full Abcann ownership for future expansion plans. In its corporate presentation (http://cnw.fm/p0PCa), ABcann notes its yield per square foot as compared to the industry average and several competitors is significantly greater – 100 percent over the industry average, in fact.
Read the full article
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer